[HTML][HTML] Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
Y Mo, M Yue, LY Yim, R Zhou, C Yu, Q Peng, Y Zhou… - …, 2023 - thelancet.com
Background HIV-1-associated immune activation drives CD4+ T cell depletion and the
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
[HTML][HTML] Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
Y Mo, M Yue, LY Yim, R Zhou, C Yu, Q Peng, Y Zhou… - eBioMedicine, 2023 - Elsevier
Background HIV-1-associated immune activation drives CD4+ T cell depletion and the
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
[HTML][HTML] Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
Y Mo, M Yue, LY Yim, R Zhou, C Yu, Q Peng… - eBioMedicine, 2023 - ncbi.nlm.nih.gov
Background HIV-1-associated immune activation drives CD4+ T cell depletion and the
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
Y Mo, M Yue, L Yim, R Zhou, C Yu, Q Peng, Y Zhou… - Ebiomedicine, 2023 - europepmc.org
Background HIV-1-associated immune activation drives CD4+ T cell depletion and the
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
Y Mo, M Yue, LY Yim, R Zhou, C Yu, Q Peng… - … - pubmed.ncbi.nlm.nih.gov
Background HIV-1-associated immune activation drives CD4+ T cell depletion and the
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
[PDF][PDF] Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
Y Mo, M Yue, LY Yim, R Zhou, C Yu, Q Peng, Y Zhou… - 2023 - researchgate.net
Background HIV-1-associated immune activation drives CD4+ T cell depletion and the
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
development of acquired immunodeficiency syndrome. We aimed to determine the role of …
Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice.
Y Mo, M Yue, LY Yim, R Zhou, C Yu, Q Peng, Y Zhou… - Ebiomedicine, 2023 - europepmc.org
HIV-1-associated immune activation drives CD4+ T cell depletion and the development of
acquired immunodeficiency syndrome. We aimed to determine the role of nicotinamide …
acquired immunodeficiency syndrome. We aimed to determine the role of nicotinamide …